Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05838508 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Physical Activity Pattern on Cardiometabolic Health

Study acronym: PACE
StatusRecruiting
PhaseNot applicable
Started2024-10-11
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Aug 30, 2026 → Aug 30, 2027
See other at-risk trials from Brigham and Women's Hospital

Amendment history

2026-09-17
Primary completion pushed: 2026-08-30 → 2027-08-30
Completion pushed: 2026-08-30 → 2027-08-30
2025-06-11
Study Identification, Study Status, Eligibility, Contacts/Locations v4
Eligibility criteria+4 characters
Inclusion Criteria: 18-45 yr old Body mass index (BMI) 2518.5 - 34.9 kg/m2 No acute, chronic or debilitating medical condi [...]
Study sitescontacts updated at 1 of 1 site
2024-11-22
Not Yet Recruiting→Recruiting Study Status, Oversight, Eligibility, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-07-20→confirmed 2024-10-11
Eligibility criteriarevised
Inclusion Criteria: 2018-45 yr old Body mass index (BMI) 2025-34.9 kg/m2 No acute, chronic or debilitating medical condit [...]
Study sites1 entry, revised
JingyiBrigham Qianand Women's Hospital
2024-06-26
Study Identification, Study Status v2
Start date2024-06-20→2024-07-20
2024-05-28
Study Status v1
Start date2023-09-01→2024-06-20
2023-04-28
Original filing
The goal of this study is to understand the interaction between the circadian system and physical activity. Participants will: * complete 2 inpatient stays * perform moderate exercise * be provided with identical meals * have frequent blood draws * provide urine and saliva samples
Trial Details
NCT Number NCT05838508
Lead Sponsor Brigham and Women's Hospital
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Life Style
Enrollment 26 participants
Start Date 2024-10-11
Primary Completion 2027-08-30 (estimated)
Study Completion 2027-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-16